PDCD1 and neoplasm: Although the ctDNA abundance was higher in the second measurement than the first, the peripheral blood ctDNA abundance was not measured at the beginning of PD-1 inhibitor treatment, the tumor was still proliferating during the period from August 26, 2017 to October 27, 2017.